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Microtubules consisting of tubulin dimers play essential roles in various cellular functions. Investi-
gating the structure–function relationship of tubulin dimers requires a method to prepare sufﬁcient
quantities of recombinant tubulin. To this end, we simultaneously expressed human a1- and b3-
tubulin using a baculovirus-insect cell expression system that enabled the puriﬁcation of 5 mg
recombinant tubulin per litre of cell culture. The puriﬁed recombinant human tubulin could be
polymerized into microtubules that glide on a kinesin-coated glass surface. The method provides
a powerful tool for in vitro functional analyses of microtubules.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Microtubules are cytoskeletal ﬁlaments formed by the sponta-
neous polymerization of tubulin heterodimers, which are each
composed of a- and b-tubulin. These highly conserved intracellular
structures play crucial roles in a wide range of cellular functions
including cell division, morphogenesis, and intracellular transport;
impaired microtubule function leads to various human diseases.
For example, mutations in tubulin genes lead to neuronal malfor-
mation [1–3], and disarrangement of tau–microtubule complexes
may lead to Alzheimer’s disease and related tauopathies [4].
To better understand the roles played by microtubules in cells
and disease, in vitro functional analyses have been performed
using tubulin puriﬁed from the mammalian brain. The puriﬁcation
method is well established and provides a biochemically useful
amount of tubulin (typically 10–30 mg tubulin per 100 g of wet
tissue) [5]. However, such native tubulin comprises more than 24
isoforms due to the multiple tubulin genes involved and various
posttranslational modiﬁcations (PTMs) [6–8], and this diversity
prevents rigorous examination of the structure–function
relationship of tubulin.We therefore need to purify isotypically pure tubulin composed
of single a- and b-tubulin polypeptides, ideally with a single, de-
ﬁned PTM state. However, heterologous expression of ab-tubulin
in bacteria has proven to be difﬁcult, likely because bacteria lack
the chaperones and cofactors required for tubulin folding and
dimerization. Using budding or ﬁssion yeast for tubulin expression
marked a breakthrough in developing a better puriﬁcation method
[9–12]. These organisms were chosen because (a) as eukaryotes
they have the chaperones and cofactors required for proper tubulin
assembly [13] and (b) they have only two a-tubulin genes, one of
which is nonessential, and one b-tubulin gene. The resultant lim-
ited number of tubulin isotypes greatly simpliﬁes the puriﬁcation
of the expressed tubulin.
Although the yeast expression system has proven to be a pow-
erful tool, the method suffers from the following limitations: First,
because of the low yield, the method requires large-scale cell cul-
tures, and obtaining 1 mg of pure yeast tubulin typically requires
25–100 g of yeast cells, which means 4–15 litre of yeast culture.
Second, the amino-acid sequence divergence between yeast and
mammalian tubulin limits analysis of the properties that are spe-
ciﬁc to mammalian tubulin.
To overcome these difﬁculties, in this study, we developed a
method to overexpress and purify recombinant human tubulin
using a baculovirus-insect cell expression system. Our method
yielded 5 mg of recombinant tubulin, composed of human a1-
and b3-tubulin, per litre of insect-cell culture (15 g of cells).
I. Minoura et al. / FEBS Letters 587 (2013) 3450–3455 3451The puriﬁed tubulin is functional in that it can be polymerized into
microtubules that support kinesin motility. The successful prepa-
ration of recombinant human tubulin opens the way for future
in vitro analyses with broad applications, especially in biomedical
research.
2. Materials and methods
2.1. Construction of baculovirus transfer plasmids
Homo sapiens a1-tubulin (TUBA1B; NP_006073) and b3-tubulin
(TUBB3; NP_006077) sequences in pUC19 plasmid were custom-
synthesized by Medical & Biological Laboratories Co. (Nagoya,
Japan). For afﬁnity puriﬁcation of the protein products, synthetic
sequences encoding a glycine-based linker (GGSGG) and a His-
tag (HHHHHHHH) were fused to the 30 end of the a1-tubulin cDNA
sequence. Sequences encoding the above glycine-based linker and
a FLAG tag (DYKDDDDK) were fused to the 30 end of the b3-tubulin
cDNA sequence. To increase expression levels, an L21 leader se-
quence [14] was added to each of these sequences just before
the start codon. The inserts were cloned into pFastBac Dual vector
(Life Technologies, Carlsbad, CA, USA); the a1-tubulin sequence
was inserted after the polyhedrin (PH) promoter by using Spe I
and Hind III sites, and the b3-tubulin sequence was inserted after
the p10 promoter by using Nhe I and Xho I sites (Fig. 1A).
2.2. Preparation of recombinant human microtubules
The transfer plasmid was used to generate recombinant baculo-
viruses using the Bac-to-Bac System (Life Technologies). To express
recombinant tubulin, HighFive cells (Life Technologies), grown to a
concentration of 2.0–2.5  106 cells/ml, were infected with the
viruses at a multiplicity of infection of 20, and cultured for aA
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Fig. 1. Expression of recombinant human a1b3-tubulin. (A) Design of the transfer
plasmid. (B) Time-course of recombinant tubulin production after viral infection
into HighFive cells. Tubulin in the cell lysate supernatant (S) and precipitate (P) was
detected by Western blotting using DM1A (anti-a-tubulin) and ab6046 (anti-b-
tubulin) antibodies. The recombinant tubulin (magenta arrowheads) migrates
slower than the endogenous tubulin (open black arrowheads) in SDS–PAGE, due to
the attached tag (see Fig. 2C). Polypeptides were quantiﬁed as shown in Fig. S1.further 24–72 h in suspension at 27 C. Cells were collected
(15 g wet weight from 1 litre of suspension culture) and lysed
for 15 min in 90 mL of PMI buffer (0.1 M PIPES, 10 mM MgSO4,
2 mM EGTA, pH 6.8) supplemented with 0.5 M 3-(1-pyridinio)-1-
propane sulfonate (NDSB201, Calbiochem, Merck KGaA, Darms-
tadt, Germany), 1% CHAPS, 5 mM DTT, 1 mM ATP, 1 mM GTP, and
protease inhibitors. This and the following steps were performed
on ice or at 4 C unless otherwise stated. The lysate was centri-
fuged for 25 min at 200,000g. The resultant supernatant was sup-
plemented with 10% (v/v) glycerol and incubated with 30 ml of
DEAE-Sepharose resin (DEAE Sepharose Fast Flow, GE Healthcare)
for 60 min. After the resin was washed with DEAE wash buffer
(0.1 M PIPES, 10 mM MgSO4, 10% glycerol, 60 mM NaCl, 1 mM
ATP, 1 mM GTP, and protease inhibitors, pH 6.8) the retained pro-
tein was eluted with the same buffer containing 0.4 M NaCl, pH 7.0.
To purify recombinant tubulin, this crude solution (40 ml) was
mixed with 4 ml of TALON resin (Clontech, Takara-Bio Inc., Ootsu,
Japan) for 30 min. His-tagged tubulin was eluted with PMG buffer
(0.1 M PIPES, 5 mM MgSO4, 10% glycerol, pH 7.0) supplemented
with 0.3 M NaCl and 0.25 M imidazole. The eluate was diluted with
an equal volume of PMI buffer supplemented with 10% glycerol,
1 mM GTP, 2 mM ATP, and 0.04% NP-40, and then mixed with
4 mL of anti-FLAG-tag antibody-conjugated resin (Sigma–Aldrich)
for 1 h. FLAG-tagged tubulin was eluted with PMG buffer supple-
mented with 2 mM EGTA, 0.15 M NaCl, 0.02% NP-40, 1 mM GTP,
and 0.2 mg/ml FLAG peptide (Sigma–Aldrich).
The resultant puriﬁed tubulin was concentrated to 3–4 mg/ml
with an Amicon Ultracel-30 K ﬁlter (Millipore, Merck KGaA), cen-
trifuged to remove aggregation, and then polymerized by adding
1–5 lM of taxol (Tocris) at 30 C for 1 h. The polymerized material
was supplemented with 2 mM ATP and 1 M NaCl, and then centri-
fuged for 12 min at 250,000g. The pellet was suspended in BRB
buffer (80 mM PIPES, 5 mMMgCl2, 1 mM EGTA, pH 6.8) containing
1 mM GTP and 0.1 mM taxol at room temperature. The microtu-
bules were stored at 4 C until use.
Alternatively, tubulin dimer eluted from the FLAG afﬁnity col-
umn was concentrated to >5 mg/ml, frozen in liquid N2 with 30%
glycerol, and then stored at 80 C until use. Upon use, tubulin
was thawed and further puriﬁed by a cycle of polymerization
and depolymerization.
2.3. Preparation of other proteins
Kinesin-1 was puriﬁed from pig brain as previously described
[15]. Brain tubulin was also puriﬁed from pig brain by two cycles
of polymerization and depolymerization, as previously described,
whereby microtubule-associated proteins (MAPs) were removed
by the addition of high-molarity PIPES buffer during the second
cycle [16]. To obtain yeast tubulin dimer fused to exactly the same
tags as those used for the recombinant human a1b3-tubulin,
Saccharomyces cerevisiae a-tubulin (TUB1) sequence was fused to
sequences encoding the glycine-based linker (GGSGG) and
His-tag (HHHHHHHH), and S. cerevisiae b-tubulin sequence with
introduced taxol-binding ability (TUB2tax) [17,18] was fused to
sequences encoding the glycine-based linker (GGSGG) and FLAG
tag (DYKDDDDK). The yeast wild-type (WT) and yeast + tag
tubulin dimers were puriﬁed using the S. cerevisiae expression
system [11].
2.4. Mass spectrometry analysis
Mass spectrometry determination of full-length tubulin
polypeptides was performed with a quadrupole time-of-ﬂight
mass spectrometer (QSTAR; AB/MDS SCIEX). See Supplementary
Materials for the detail.
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Fig. 2. Puriﬁcation of recombinant a1b3-tubulin. (A) Puriﬁcation ﬂow chart. (B)
SDS–PAGE of samples from each puriﬁcation step. (C) Tubulin in the DEAE eluent
was analyzed by Western blotting using anti-a-tubulin, anti-b-tubulin, anti-His tag,
and anti-FLAG tag antibodies. Red and blue arrowheads indicate endogenous a- and
b-tubulin, respectively; red and blue arrows indicate recombinant a1- and b3-
tubulin, respectively. (D) Yield and composition of tubulin at each puriﬁcation step
determined by gel densitometry and protein concentration measurements.
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Microtubules and microtubule gliding on kinesin-coated sur-
faces were observed and analysed by standard methods as previ-
ously described [11,19]. See also Supplementary Materials for the
detail.
3. Results
3.1. Expression and puriﬁcation of recombinant tubulin
To express and purify recombinant tubulin in an insect-baculo-
virus expression system, we need to ﬁnd a condition that satisﬁes
the following requirements; (1) the expressed a- and b-tubulins
form a soluble dimer in the cell lysate; and (2) the tubulin dimer
composed of recombinant a- and b-tubulin can be separated from
endogenous tubulin with high purity. To this end, we adopted the
strategy of expressing the recombinant tubulin fused with tags and
separating it from endogenous tubulin by using afﬁnity chroma-
tography. Fig. 1A shows the design of the baculoviral transfer plas-
mid used for the expression of human tubulin in insect cells. The
sequences encoding His and FLAG tags were fused at the C-termi-
nus of human a1- and b3-tubulin genes, respectively, and cloned
into a single baculoviral transfer plasmid.
The recombinant viruses produced from the transfer plasmids
were infected into HighFive cells, and the time course of expression
after the infection was examined byWestern blot analysis (Fig. 1B).
The amount of recombinant tubulin in the soluble fraction reached
a maximum level at 33–48 h and gradually declined thereafter
(Fig. S1). In parallel, the expression level of endogenous tubulin de-
creased, indicating that the increasing number of a1- and b3-tubu-
lin polypeptides might have taken over the molecular machinery,
such as chaperones, involved in the folding and dimer formation
of the endogenous tubulin [13]. A large fraction of recombinant
tubulin also appeared in the insoluble fraction, probably due to a
limited capacity for folding and dimerization [20].
We next puriﬁed a1b3-tubulin dimer from HighFive cells
harvested at 33 h postinfection (Fig. 2A). The cell lysate was ﬁrst
fractionated through DEAE-Sepharose ion-exchange chromatogra-
phy. The SDS–PAGE analysis resolved four species of tubulin poly-
peptides in DEAE eluent (Fig. 2B, lane 2), identiﬁed as endogenous
a-tubulin, recombinant a1-tubulin, endogenous b-tubulin, and re-
combinant b3-tubulin by Western blot analysis (Fig. 2C). The DEAE
chromatography step enriched the tubulin content to 45% of total
protein. From this DEAE eluent, endogenous a-tubulin was ﬁrst re-
moved using the His-afﬁnity column, and endogenous b-tubulin
was subsequently removed using the FLAG-afﬁnity column
(Fig. 2B–D). The a1b3-tubulin dimer eluted from the FLAG-afﬁnity
column was polymerized into microtubules, and washed with a
solution containing high salt and ATP to remove MAPs. The typical
yield of a1b3-microtubule is 5 mg per litre of culture (> 99% pur-
ity). The microtubules can be stored at 4 C for two weeks in the
presence of taxol, provided that the molar concentration of taxol
is higher than that of tubulin.
The presence of both endogenous and recombinant b-tubulin in
the eluent from the His-afﬁnity column indicates that His-tagged
a1-tubulin can form dimers with either type of b-tubulin
(Fig. 2D). Vice versa, when DEAE eluent was ﬁrst applied to the
FLAG-afﬁnity column instead of the His-afﬁnity column, the eluent
from the FLAG-afﬁnity column contained both endogenous and re-
combinant a-tubulin, indicating that b3-tubulin can form dimers
with either type of a-tubulin (data not shown). Because recombi-
nant tubulin forms dimers with its endogenous counterpart, cer-
tain fractions of soluble a1- and b3-polypeptides originally
expressed in the HighFive cells (Fig. 1B) were inevitably lost during
the puriﬁcation process (Fig. 2D).3.2. Posttranslational modiﬁcation of tubulin
To examine how the puriﬁed a1b3-tubulin is posttranslational-
ly modiﬁed, the sample was analyzed using electrospray ionization
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which comprised various polypeptides, recombinant tubulin was
composed of only a few polypeptides (Fig. 3A and B). In the mass
spectrum of the recombinant a1- and b3-tubulin, three major
peaks with mass sizes of 51564, 51605, and 51742 Da were
detected (ﬁlled arrowheads in Fig. 3B). The ﬁrst peak corresponds
to the recombinant a1-tubulin and the second corresponds to acet-
ylated a1-tubulin (theoretical mass: 51564.1 and 51606.1 Da). This
result was conﬁrmed by Western blot analysis using anti-acety-
lated-a-tubulin antibody (Fig. 3D). The mass of the third peak coin-
cides with the theoretical mass of b3-tubulin (51742.9 Da).
In addition to the three major peaks, three minor peaks corre-
sponding to taxol-bound nonacetylated and acetylated a1-tubulin
and b3-tubulin (52416, 52461, and 52596 Da, respectively) were
detected. More minor peaks, likely due to tubulin polypeptides0
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Fig. 3. PTM of a1b3-tubulin analyzed by mass spectrometry and Western blotting.
Deconvoluted mass spectra of (A) tubulin puriﬁed from pig brain, (B) human WT
a1b3-tubulin, and (C) a1b3-tubulin with a K40R mutation on a1-tubulin. Filled
arrowheads represent recombinant tubulins (51564, 51605, and 51742 Da in B, and
51592 and 51742 Da in C); arrows represent taxol-bound tubulins (+854 Da); open
arrowheads (51626 and 51779 Da) indicate peaks that might represent tubulin with
bound ions such as Cl or OH. See Fig. S2 for raw data. (D) Western-blot analysis of
the samples in A–C using antibodies speciﬁc to acetylated, polyglutamylated,
detyrosinated, and D2 tubulin.with nonspeciﬁcally bound ions, solvent, etc., were also visible,
but no peaks representing well-known PTMs such as glycylation
(+57 Da), phosphorylation (+81 Da), or glutamylation (+129 Da)
were detected (Fig. 3B).
Although the result indicates the potential value of this recom-
binant tubulin for studying the effects of acetylation on microtu-
bule function, in studies where the acetylation is not a subject of
analysis, charge and mass variation of a1-tubulin caused by
acetylation/deacetylation could complicate the interpretation.
Thus, to prepare isotypically pure tubulin with a single PTM state,
we prepared non-acetylatable a1b3-tubulin by replacing Lys 40 in
a1-tubulin with Arg [21]. The expression pattern and yield of this
a1-K40R/b3 (K40R) mutant tubulin were similar to those of human
WT tubulin, and the spectrum showed a single peak for both a1-
and b3-tubulin (Fig. 3C). The K40R tubulin was used in the subse-
quent functional analyses.3.3. Functional analysis
To measure the assembly kinetics, puriﬁed K40R tubulin
(0.2 mg/ml) was mixed with 2 lM taxol, and the process of poly-
merization was monitored by 350-nm light scattering. The result
shows slower polymerization of recombinant tubulin compared
to pig brain tubulin (Fig. 4A).
Tubulin assembled in the presence of 2 lM taxol for 30 min was
further stabilized by increasing the taxol concentration to 50 lM
and was examined under a dark-ﬁeld microscope. The recombi-
nant microtubules appeared uniform, like those isolated from pig
brain (Fig. 4B), but with a greater length than that of brain micro-
tubules (16.2 ± 11.9 (N = 72, mean ± SD) and 7.9 ± 10.2 lm (N = 81)
for recombinant and brain microtubules, respectively, Fig. 4C).
These properties of recombinant tubulin, slower polymerization
and assembly to longer microtubules, can be attributed to the
low sensitivity of b3-tubulin for taxol. An earlier study showed that
in the presence of taxol, b3-depleted tubulin assembles faster and
produces shorter microtubules, as compared to unfractionated
tubulin [22].
Kinesin-microtubule interactions were then tested in a micro-
tubule-gliding assay using kinesin. The K40R microtubules glided
on the kinesin-coated surface at a velocity of 0.64 ± 0.08 lm/s
(n = 120), which is slightly, but signiﬁcantly, slower than that of
pig brain microtubules (0.70 ± 0.09 lm/s, n = 120; P = 9.7  107,
t-test; Fig. 5, Movies S1 and S2).
Because the C-terminal region of tubulin is a motor-binding
site, we considered that the His and FLAG tags might have inter-
fered with the kinesin–microtubule interaction and reduced the
gliding velocity. To evaluate the effect of these tags on motility,
we conducted a separate experiment comparing the gliding
velocity of yeast microtubules with and without tags at the tubulin
C-terminal tails. Contrary to our hypothesis, the velocity of
yeast + tag microtubules (0.81 ± 0.06 lm/s, n = 120) was 5% higher
than that of yeast WT microtubules (0.77 ± 0.05 lm/s, n = 120;
P = 1.0  107, t-test; Fig. 5). This result suggests that the observed
velocity difference between recombinant and pig brain microtu-
bules could be due to their differences in the PTM state, primary
structure, or both, but were not due to tags.4. Discussion
In this study, we established a method to express and purify
experimentally usable amounts of human a1b3-tubulin in a
baculovirus-insect cell system. Our new method is easier and more
efﬁcient than our previous yeast-expression system [11] and a
subsequently improved method [23]. We obtained 5 mg of tubulin
from 15 g of cells cultured in 1 litre of culture medium. This
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from animal tissues, where typically 10–30 mg of tubulin is ob-
tained from 100 g of pig brain [5].
With regard to the PTMs, the acetylation of Lys40 caused a mass
variation in recombinant a1-tubulin polypeptides. To produce
a1b3-tubulin with a single PTM state, we suppressed the acetyla-
tion using a K40R mutant, but for future studies examining the ef-
fect of acetylation on microtubule function, we may be able to
produce completely acetylated/deacetylated tubulin by using WT
a1b3-tubulin as a substrate for acetyltransferase/deacetylase
[24,25].
The recombinant a1b3-tubulin can also become a substrate for
enzymes for other PTMs such as polyglutamylation or polyglycyla-
tion [26,27]. However, there may be an issue with the use of our
expression system for studying the effects of those PTMs, if the tags
attached at the tubulin C-terminus interfere with the PTMs at the
C-terminal tail of tubulin. To avoid such a potential problem, wetried to express N-terminally tagged tubulin, but the protein re-
mained insoluble (data not shown). To use recombinant tubulin
for studying PTMs at the C-terminus, technical improvements are
required.
Despite the attached tags, our recombinant microtubules can
move on a kinesin-coated glass surface at velocities comparable to
those of brain microtubules. This allows us to analyze the effect of
disease-related mutations in mammalian tubulin on kinesin motil-
ity. To date, manymutations in both a- and b-tubulin have been re-
ported to cause developmental disorders and brain malfunctions in
humans [28], and some of the patients’ symptoms are thought to be
due to impaired kinesinmotility [2,29].With our technical advance-
ment, we can now systematically analyze the effect of these muta-
tions at different levels such as in vitro, and in cells and animals, and
thus may be able to elucidate the molecular mechanisms by which
the mutations lead to pathogenesis.
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